Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Amrubicin hydrochloride

EU orphan designation number: EU/3/08/538   
Active ingredient: Amrubicin hydrochloride
Indication: Treatment of small cell lung cancer
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/04/2008 Centralised Orphan - Designation EMEA/OD/113/07 (2008)1319 of 02/04/2008
23/10/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/113/07/T/01 (2008)6246 of 21/10/2008
30/05/2011 Other procedure EMEA/OD/113/07